RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All Non-opioids/OTC Articles

Cyproheptadine may be useful in treating chronic pain conditions such as sleep disorders, sexual dysfunction, refractory headaches, and more.
Sunascen Therapeutics have developed a line of non-habit forming pain relievers that are developed with the patient in mind.
Tanezumab is the first investigational humanized monoclonal immunoglobulin G2 antibody, preventing the binding of NGF to its receptors to block the pain response pathway.
Small doses could help children suffering from various types of inflammation and pain.
Nonopioid Management Just as Impactful as Opioids for Knee/OA Pain
Chronic neuropathy treatment does not offer much pain relief for patients.
Ask the Expert: A discussion of the pain relief potential from Na1.7 Inhibitors for neuropathic pain disorders.
Recommendations concerning liver function tests for Duloxetine, prescribed for neuropathic pain.
Ask the Expert authors examine the role for low-dose ketamine for treatment of CRPS.
Pain expert offers clinical guidance to a commonly asked question about the proper, safe, and effective dose of gabapentin when treating neuropathic pain.
2016 review of current and emerging therapies for opioid-induced constipation, a common side effect of chronic opioid therapy.
To help reduce the need for opioids, IV acetaminophen could be included in the initial and perioperative pain control protocol of burn patients based on its analgesic effect, safety profile, and easy accessibility.
Forest Tennant, MD, DrPH, picks for 2016 Practical Clinical Advances in pain management—oral ketamine and metformin.
Dr. John Claude Krusz describes his protocol for the use of subanesthetic dosages of IV agents—ketamine, lidocaine, propofol—in an outpatient headache clinic.
Canadian researchers discuss 6 common concerns of patients and physicians regarding cannabis use for pain management.
SHOW MAIN MENU
SHOW SUB MENU